Research Article - (2011) Volume 2, Issue 3

Identification of Causative Species in Cutaneous Leishmaniasis Patients Using PCR-RFLP

Eroglu F1*, Koltas IS1 and Genc A2
1Department of Parasitology, Faculty of Medicine, Cukurova University, Balcali, Adana, Turkey
2Adiyaman University, Vocational School of Health Services, Altinsehir, Adiyaman, Turkey
*Corresponding Author: Dr. Eroglu F, Department of Parasitology, Faculty of Medicine, Cukurova University, Balcali, Adana, Turkey Email:

Abstract

Cutaneous leishmaniasis (CL) in Cukurova located in the southern part of Turkey is a public health problem. We assessed the efficiency of a PCR method in establishing the diagnosis of CL. We used two different targets, kinetoplast DNA (kDNA) for diagnosis and a mini-exon gene for species typing. 64 smear samples were taken from clinically CL suspected cases. The DNA was amplified kinetoplast DNA (kDNA) by using the polymerase chain reaction (PCR) with universal primers 13A-13B, specific for the Leishmania genus and DNA was amplified in the mini-exon region by PCR with Fme-Rme primers, specific for Leishmania species. We compared the sensitivity and specificity of conventional microscopy with kDNA and mini-exon PCR. kDNA PCR was found to have a specificty of 58.8% and a sensitivity of 100%, respectively. Furthermore, we performed a restriction fragment length polymorphism (RFLP) analysis on the PCR products of mini-exon for the genotyping of Leishmania species. Interestingly, the PCR-RFLP result showed that 31.5% of the isolates had Leishmania infantum ( L.infantum ) in CL cases without visceral leishmaniasis (VL) history.

Keywords: Cutaneous leishmaniasis; PCR; RFLP; L.infantum

Introduction

Cutaneous leishmaniasis (CL) is a skin disease caused by the Leishmania species [7,20]. CL is caused by Leishmania major (L.major), Leishmania aethiopica (L.aethiopica), Leishmania tropica (L.tropica), Leishmania infantum (L.infantum) and Leishmania donovani (L.donovani), in the Old World [24]. CL is endemic diseases in southeastern Turkey [10]. The causative agent of CL in this region is mainly L.tropica [2]. However, recently researches have reported that L.infantum is isolated from CL patients [30,32] CL is most frequently diagnosed by clinical evaluation and its typical acute lesions can be confused with other dermatological problems, such as sporotrichosis [1,25]. Therefore, a clinical evaluation is not enough for a conclusive diagnosis of CL, so the laboratory diagnosis is important for CL diagnosis [27,28]. The traditional diagnostic methods of CL consist of the microscopic examination of smears after Giemsa staining, culture and serological techniques [29]. These techniques are adequate for the diagnosis of CL, but these techniques are not adequate for the discrimination of species due to the morphological similarity of different Leishmania species [11,12].

Recently, several molecular methods, especially those based on PCR, have been used for the diagnosis and identification of Leishmania species [16,26]. The targets for amplification with PCR serve either nuclear DNA, such as the SSUrRNA gene, mini-exon regions, the gp63 gene locus, microsatellite DNA, the internal transcribed spacer 1 (ITS1) region or extrachromosomal DNA, such as the repetitive kDNA minicircles [5,17]. The ITS 1 region of the rRNA genes (40 to 200 copies) and ITS 1 region have previously been expoited for Old World species discrimination using restriction fragment length polymorphisms [31]. KDNA minicircles (10000 to 20000 copies) are used as ideal molecular targets for the diagnosis of the Leishmania genus [23]. The miniexon regions of the rRNA genes (40 to 200 copies) have been used to identify Leishmania species, if the mini-exon amplicon is digested with restriction enzymes [17]. The PCR-RFLP method has reported sensitivity from 90% to 100% for identification of Leishmania sp [13], so we used PCR-RFLP method for identification of Leishmania sp in our study.

In this study, we used kDNA for the diagnosis and the mini-exon region for the species typing of CL smear samples. We calculated the sensitivities and specificities of kDNA and the mini-exon PCR assay using a microscopic examination as the gold standard of CL diagnosis. However, Leishmania isolates have identified genotypes using the miniexon region by PCR-RFLP.

Materials and Methods

Cases, microscopic examination and DNA isolation

The smear samples were taken from 64 cases, which were suspected for CL. The participants were living in the locality were informed about CL disease, a questionnaire was applied to people suspected of having CL. Then, these lesions were cleaned with 70% alcohol. Using a sterile lancet, 2-3 mm long superficial incisions were made on the margins of the lesion. A smear of dermal tissue scrapings was collected from each patient. The smear samples were stained with Giemsa and then examined with (oil X100 objective) for the presence of the amastigote form of the parasite. The amastigotes were quantitated according to the method by [6] and the density of the amastigotes was 10 to 100 amastigotes per high power field (hpf).

The genomic DNA was extracted from all of the smear samples using the Agencourt Genfind v2 DNA isolation kit (Beckman Coulter, Beverly, USA) according to the manufacturer's protocol.

PCR amplification and restriction digestion

The kDNA PCR using the primers 13A (5'-GTG GGG GAG GGG CGT TCT-3') and 13B (5'-ATT TTC CAC CAA CCC CCA GTT-3') was carried out essentially [21]. On the other hand, mini-exon PCR using the primers Fme (5'-ACA GAA ACT GAT ACT TAT ATA GCG- 3') and Rme (5'-TAT TGG TAT GCG AAA CTT CCG-3') was used to identify Leishmania species [17]. In addition, it was used to compare PCR methods (kDNA and mini-exon) and microscopic examinations.

All PCR reaction mixtures consisted of PCR buffer 1X (75 mM Tris-HCl, PH 8.3 and 20 mM (NH4)2SO4, 1.5 mM MgCl2,1 U Taq polymerase (Fermantas SB83), 0.2 mM dNTPs (Fermantas RO 191), 12% DMSO (Fluka Chemika, Germany), 0.5 pmol of each primer, and 5 µL of the DNA sample. DNA amplification was performed by a first cycle at 94°C for 5 mins, followed by 40 cycles at 94°C for 1 min, 54°C for 1 min, and 72°C for 1 min and 30 sec, with a final extension cycle at 72°C for 10 mins. The PCR products were analysed on 2% agarose gels by electrophoresis at 100 V in 1 X Tris-Boric-EDTA buffer (0.04 mM Tris-boric and 1mM EDTA PH 8) and visualized by UV light after being stained with ethidium bromide.

Mini-exon PCR products (10-20 µL) were digested with the EaeI restriction enzyme (Takara, 1123A) according to the manufacturer's instructions, and the restriction fragments were analysed by 3% agarose gel electrophoresis. Fragment sizes were determined with bands of a DNA length Standard (50-1000 / 100-1000 bp ladder, Bio-Basic GM345/GM346).

Results

Specimens from 64 suspected CL patients infected in the Cukurova region, in the southern part of Turkey, were examined by microscopic examination, kDNA and mini-exon PCR (Table 1). The microscopic examination results were positive in 30 (46.9 %) and negative in 34 (53.1%) cases (Table 2).

kDNA PCR Microscopic Examination Mini-exon PCR
+ 22 13 +
- 0 0
+ 8 1 -
- 0 20
Total 30 34  

Table 1: Results of microscopic examination, kDNA PCR and Mini-exon PCR.

44 (68.75 %) of the 64 smear samples were positive and 20 (31.25%) smear samples were negative, according to kDNA PCR. When we compared the sensitivity and specificity of the kDNA PCR and the microscopic examination, a sensitivity of 58.8% and 100% were found, respectively (Table 2). 35 (54.7%) of these samples were found to be positive and 29 (45.3%) smear samples were found to be negative by mini-exon PCR. We calculated the specificity and sensitivity of the mini-exon PCR according to the microscopic examination; the specificity was 85.2% and the sensitivity was 100% (Table 3).

Assay Positive Negative %of Positive %of Negative Sensitivity Specificity
kDNA PCR Mini-exon PCR kDNA PCR Mini-exon PCR
Microscopic Examination 30 34 46.9 53.1 68 85 100 100

Table 2: Results of microscopic examination compared with kDNA PCR and mini-exon PCR.

Assay Positive Negative %of Positive %of Negative Sensitivity Specificity
ME* Mini-exon PCR ME* Mini-exonPCR
kDNA PCR 44 20 68.75 31.25 100 100 58.8 68.9

*ME: Microscopic examination

Table 3: Results of kDNA PCR compared with microscopic examination and mini-exon PCR.

The kDNA PCR products were considered positive when band of correct size kDNA of ~ 120 bp was observed for Leishmania isolates (Figure 1). The mini-exon PCR product sizes of cutaneous isolates were found to be approximately 403-435 bp for Leishmania sp (Figure 2). However, to be sure about the exact type of species, the PCR products were digested with EaeI for RFLP. 11 mini-exon PCR according to the microscopic examination; the specificity was 85.2% and the sensitivity was 100% (Table 4).

bacteriology-parasitology-cutaneous-isolates

Figure 1: PCR products of Leishmania isolates. Lanes 1-3: Leishmania isolates. PCR products of cutaneous isolates with 13A-13B primer of kDNA PCR. Lane 4: 50-1000 bp DNA ladder.

bacteriology-parasitology-mini-exon

Figure 2: PCR products of cutaneous isolates with Fme-Rme primer of mini-exon PCR. Lane 1: 50-1000 bp DNA ladder, lane 2-4: Leishmania isolates.

Assay Positive Negative %of Positive %of Negative Sensitivity Specificity
ME* kDNA PCR ME* kDNA PCR
Mini-exon PCR 35 29 54.7 45.3 100 79.5 85.2 100

*ME: Microscopic examination

Table 4: Results of mini-exon PCR compared with microscopic examination and kDNA PCR.

The kDNA PCR products were considered positive when a band of correct size kDNA of ~ 120 bp was observed for Leishmania isolates (Figure 1). The mini-exon PCR product sizes of cutaneous isolates were found to be approximately 403-435 bp for Leishmania sp (Figure 2). However, to be sure about the exact type of species, the PCR products were digested with EaeI for RFLP. 11 mini-exon PCR samples (31.5%) produced two bands approximately 327 and 108 bp after digestion with EaeI indicating L.infantum and the other 24 of ITS 1 PCR products (68.5%) produced two bands approximately 227 and 178 bp after digestion with EaeI indicating L.tropica (Figure 3). We did not find any other Leishmania species in this study.

bacteriology-parasitology-band-patterns

Figure 3: RFLP band patterns of cutaneous isolates after digestion with EaeI. A:Lane 1: 50-1000 bp DNA ladder, lane 2-4: L. infantum, B: Lane 1: 100-1000 bp DNA marker, lanes 2-4: L. tropica.

Discussion

A diagnosis of CL can be made on the basis of clinical and epidemiological data, but it has to be confirmed by laboratory methods [9]. All conventional methods such as stained smear, culture, histopathology and immunologic methods, employed for the diagnosis of CL has modest to low rates of positivity [18]. Microscopic examination has been the gold Standard for CL diagnosis for the last 100 years [19,22]. However, it has reported sensitivity from 42% to 67% [26]. We found similar results in our study regarding the sensitivity of microscopic examination for CL diagnosis.

PCR offers certain advantages over conventional methods for the diagnosis and characterization of CL [22]. When approximately applied, PCR can be more specific, sensitive, versatile, and rapid than conventional methods; in addition, genetic information can be obtained in the process [4].

PCR has shown high sensitivities, varying from 80-100 %, as reported by various groups working on CL diagnosis [15,20]. The positivity rate of kDNA PCR was found to be 99.3% [8], 87% [1], and 100% [4]. Our study confirms these findings, showing that kDNA PCR has a specificty of 58.8% and sensitivity of 100%, while the specificity and sensitivity of mini-exon PCR were found to be 85.2% and 100%, respectively. kDNA PCR was found to be superior to parasitological methods for the diagnosis of CL in our study. However, the PCR-RFLP assay targeting mini-exon region in nuclear DNA was shown to be useful in the diagnosis and identification of speicies of Leishmania in this study.

CL in the Old World is mainly caused by L.major, L.tropica, L.aethiopica and occasionally L.infantum [14]. It has been reported that L.infantum strains may be causng CL in the Middle-East, Africa, Southern Europe, Iran and Tunisia [3,21]. Chargui et al. [8] Isolated L.infantum (1%) from leisons of the kin and they found that 99% were L.major in Tunisia by zymodeme analysis [8]. However, L.infantum in CL cases without VL history has been reported in our country [30,32]. In our study, 68.5% were probably caused by L.tropica and 31.5% by L.infantum. We found that L.infantum could cause CL but these findings are very important for prescribing the appropriate therapy as L.infantum strains may be enter the visceral. However, more studies are needed to confirm this issue.

References

  1. Al-Jawabreh A, Schoenian G, Hamarsheh O, Presber W (2006) Clinical diagnosis of cutaneous leishmaniasis: A comparison study between standardized graded direct microscopy and ITS1-PCR of Giemsa-stained smears. Acta Tro 99: 55-61.
  2. Allahverdiyev AM, Uzun S, Bagirova M, Durdu M, Memisoglu HR (2004) A sensitive new microculture method for diagnosis of cutaneous leishmaniasis. Am J Trop Med Hyg 70: 294-297.
  3. Antinori S, Gianelli E, Calattini S, Longhi E, Gramiccia M, et al. (2005) Cutaneous leishmaniasis: an increasing threat for travellers. Clin Microbiol Infect 11: 343-346.
  4. Belli A, Rodriguez B, Aviles H, Harris E (1998) Simplified polymerase chain reaction detection of new world Leishmania in clinical specimens of cutaneous leishmaniasis. Am J Trop Med Hyg 58: 102-109.
  5. Bensoussan E, Nasereddin A, Jonas F, Schnur LF, Jaffe CL (2006) Comparison of PCR assays for diagnosis of cutaneous leishmaniasis. J Clin Microbiol 44: 1435-1439.
  6. Boggild AK, Miranda-Verastegui C, Espinosa D, Arevalo J, Adaui V, et al. (2007) Evaluation of a microculture method for isolation of Leishmania parasites from cutaneous lesions of patients in Peru. J Clin Microbiol 45: 3680-3684.
  7. Castilho TM, Shaw JJ, Floeter-Winter LM (2003) New PCR assay using glucose-6-phosphate dehydrogenase for identification of Leishmania species. J Clin Microbiol 41: 540-546.
  8. Chargui N, Bastien P, Kallel K, Haouas N, Akrout FM, et al. (2005) Usefulness of PCR in the diagnosis of cutaneous leishmaniasis in Tunisia. Trans R Soc Trop Med Hyg 99: 762-768.
  9. de Oliveira CI, Báfica A, Oliveira F, Favali CB, Correa T, et al. (2003) Clinical utility of polymerase chain reaction-based detection of Leishmania in the diagnosis of American cutaneous leishmaniasis. Clin Infect Dis 37: 149-153.
  10. Demirel R, Erdogan S (2009) Determination of high risk regions of cutaneous leishmaniasis in Turkey using spatial analysis. Turkiye Parazitol Derg 33: 8-14.
  11. Genetu A, Gadisa E, Aseffa A, Barr S, Lakew M, et al. (2006) Leishmania aethiopica: Strain identification and characterization of superoxide dismutase-B genes. Exp Parasitol 113: 221-226.
  12. Gomes AH, Ferreira IM, Lima ML, Cunha EA, Garcia AS, et al. (2007) PCR identification of Leishmania in diagnosis and control of canine leishmaniasis. Vet Parasitol 144: 234-241.
  13. Hajjaran H, Vasigheh F, Mohebali M, Rezaei S, Mamishi S, et al. (2011) Direct diagnosis of Leishmania species on serosity materials punctured from cutaneous leishmaniasis patients using PCR-RFLP. J Clin Lab Anal 25: 20-24.
  14. Hailu A, Di Muccio T, Abebe T, Hunegnaw M, Kager PA, et al. (2006) Isolation of Leishmania tropica from an Ethiopian cutaneous leishmaniasis patient. Trans R Soc Trop Med Hyg 100: 53-58.
  15. Isaza DM, Arboleda M, Restrepo M, McCann SH, Barker DC (2002) Validation of the polymerase chain reaction for the diagnosis of human cutaneous leishmaniasis in north-west Colombia. Trans R Soc Trop Med Hyg 96: 165-168.
  16. Kato H, Uezato H, Katakura K, Calvopiña M, Marco JD, et al. (2005) Detection and identification of Leishmania species within naturally infected sand flies in the andean areas of ecuador by a polymerase chain reaction. Am J Trop Med Hyg 72: 87-93.
  17. Marfurt J, Niederwieser I, Makia ND, Beck HP, Felger I (2003) Diagnostic genotyping of old and new world Leishmania species by PCR-RFLP. Diagn Microbiol Infect Dis 46: 115-124.
  18. Marfurt J, Nasereddin A, Niederwieser I, Jaffe CL, Beck HP, et al. (2003) Identification and differentiation of Leishmania species in clinical samples by PCR amplification of the miniexon sequence and subsequent restriction fragment lenght polymorphism analysis. J Clin Microbiol 41: 3147-3153.
  19. Marques MJ, Volpini AC, Machado-Coelho GL, Machado-Pinto J, da Costa CA, et al. (2006) Comparison of polymerase chain reaction with other laboratory methods for the diagnosis of American cutaneous leishmaniasis: diagnosis of cutaneous leishmaniasis by polymerase chain reaction. Diagn Microbiol Infect Dis 54: 37-43.
  20. Marques MJ, Volpini AC, Genaro O, Mayrink W, Romanha AJ (2001) Simple form of clinical sample preservation and Leishmania DNA extraction from human lesions for diagnosis of American cutaneous leishmaniasis via polymerase chain reaction. Am J Trop Med Hyg 65: 902-906.
  21. Motazedian H, Karamian M, Noyes HA, Ardehali S (2002) DNA extraction and amplification of Leishmania from archived, giemsa-stained slides, for the diagnosis of cutaneous leishmaniasis by PCR. Ann Trop Med Parasitol 96: 31- 34.
  22. Mimori T, Matsumoto T, Calvopiña MH, Gomez EA, Saya H, et al. (2002) Usefulness of sampling with cotton swab for PCR-diagnosis of cutaneous leishmaniasis in the new world. Acta Trop 81: 197-202.
  23. Nicolas L, Milon G, Prina E (2002) Rapid differentiation of old world Leishmania species by lightcycler polymerase chain reaction and melting curve analysis. J Microbio Methods 51: 295-299.
  24. Odiwuor SO, Saad AA, De Doncker S, Maes I, Laurent T, et al. (2011) Universal PCR assays for the differential detection of all Old World Leishmania speices. Eur J Clin Microbiol Infect Dis 30: 209-218.
  25. Reithinger R, Dujardin JC (2007) Molecular diagnosis of leishmaniasis current status and future applications. J Clni Microbiol 45: 21-25.
  26. Rodrigues EH, Felinto de Brito ME, Mendonça MG, Werkhäuser RP, Coutinho EM, et al. (2002) Evaluation of PCR of American cutaneous leishmaniasis in an area of endemicity in northeastern Brazil. J Clin Microbiol 40: 3572-3576.
  27. Romero GA, Guerra MV, Paes MG, Cupolillo E, Bentin Toaldo C, et al. (2001) Sensitivity of the polymerase chain reaction for the diagnosis of cutaneous leishmaniasis due to Leishmania (Viannia) guyanensis. Acta Trop 79: 225-229.
  28. Weigle KA, Labrada LA, Lozano C, Santrich C, Barker DC (2002) PCR based diagnosis of acute and chronic cutaneous leishmaniasis caused by Leishmania (Viannia). J Clin Microbiol 40: 601-606.
  29. Wortmann G, Hochberg L, Houng HH, Sweeney C, Zapor M, et al. (2005) Rapid identification of Leishmania complexes by a real-time PCR assay. Am J Trop Med Hyg 73: 999-1004.
  30. Serin MS, Daglioglu K, Bagirova M, Allahverdiyev A, Uzun S, et al. (2005) Rapid diagnosis and genotyping of Leishmania isolates from cutaneous and visceral leishmaniasis by microcapillary cultivation and polymerase chain reaction-restriction fragment length polymorphism of miniexon region. Diagn Microbiol Infect Dis 53: 209-214.
  31. Schönian G, Nasereddin A, Dinse N, Schweynoch C, Schallig HD, et al. (2003) PCR diagnosis and characterization of Leishmania in local and imported clinical samples. Diagn Microbiol Microbiol Infect Dis 47: 349-358.
  32. Toz SO, Nasereddin A, Ozbel Y, Ertabaklar H, Culha G, et al. (2009) Leishmaniasis in Turkey: molecular characterization of Leishmania from human and canina clinical samples. Trop Med Int Health 14: 1401-1406.
Citation: Eroglu F, Koltas IS, Genc A (2011) Identification of Causative Species in Cutaneous Leishmaniasis Patients Using PCR-RFLP. J Bacteriol Parasitol 2:113.

Copyright: © 2011 Eroglu F, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.